Dalton Lee Colhouer, PHARM D in Onaga, KS - Pharmacist

Dalton Lee Colhouer, PHARM D is a Pharmacist based in Onaga, Kansas. Dalton Lee Colhouer is licensed to practice in Kansas (license number 1-100807) and his current practice location is 300 Leonard St, Onaga, Kansas. He can be reached at his office (for appointments etc.) via phone at (785) 889-7181.

NPI number for Dalton Lee Colhouer is 1922699636 and his current mailing address is 300 Leonard St, Onaga, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1922699636.

Contact Information

	Dalton Lee Colhouer, PHARM D
	300 Leonard St, Onaga, KS 66521-9484
	(785) 889-7181
	Not Available

Healthcare Provider's Profile

Full Name	Dalton Lee Colhouer
Gender	Male
Speciality	Pharmacist
Location	300 Leonard St, Onaga, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1922699636
Provider Enumeration Date: 01/27/2021
Last Update Date: 02/09/2023

Medical Identifiers

Medical identifiers for Dalton Lee Colhouer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1922699636	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-100807 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dalton Lee Colhouer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dalton Lee Colhouer, PHARM D 300 Leonard St, Onaga, KS 66521-9484 Ph: (785) 889-7181	Dalton Lee Colhouer, PHARM D 300 Leonard St, Onaga, KS 66521-9484 Ph: (785) 889-7181

News Archive

Lexicon receives FDA Orphan Drug designation for telotristat etiprate to treat carcinoid syndrome

Lexicon Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted its request for Orphan Drug designation for telotristat etiprate (LX1032) for the treatment of carcinoid syndrome.

Electronic compendia develops new educational tool for nursing students

This e-compendium solution was also unique internationally when we launched it,» reports Atle Løkken, head of the NettOp department for web-based learning at the UiS.

CBO: Obama's budget would reduce Medicare spending by $364B

The Congressional Budget Office estimated Friday that President Obama's budget would reduce Medicare spending by $364 billion over the next decade and would reduce future budget deficits. The White House and Congress will likely soon need to work on a long-term budget solution as the nation again approaches its debt limit.

Smith & Nephew launches new operative hysteroscopy device

Smith & Nephew's Endoscopy Division announced the launch of the TRUCLEAR(TM) System, an operative hysteroscopy device, which is now widely available in the United States.

Dalton Lee Colhouer, PHARM D - Pharmacist in Onaga, KS